Calliditas moves its Annual General Meeting 2020 to June 25
Calliditas Therapeutics AB (publ) (“Calliditas”) today announced that due to the recent Covid-19 pandemic, the Company has decided to move its Annual General Meeting 2020 to June 25, 2020.The Annual Report for 2019 is expected to be published on April 28, 2020. The information was sent for publication, through the agency of the contact persons set out above, on March 30, 2020 at 2:00 p.m. CET. For further information, please contact: Renée Aguiar-Lucander, CEO, Calliditas Email: renee.lucander@calliditas.com Telephone: +46 722 52 10 06 Mikael Widell, Head of Communications